Molecular Diagnostics & Early Detection

Molecular alterations can reveal malignant transformation before conventional morphological changes become apparent. We identify and validate biomarkers reflecting oncogenic activity, genomic instability, and epigenetic dysregulation. Translating these insights into robust diagnostic approaches, we aim to improve early detection, risk stratification, and clinically relevant molecular classification.